Patents by Inventor Hiu LU

Hiu LU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THREE-DIMENSIONAL PRINTING SYSTEM AND METHODS OF USE
    Publication number: 20170071712
    Abstract: A three-dimensional printing system including a feed source of uncured filled resin material, a print head configured to apply discrete layers of a composition including upconversion phosphors, and a radiation source configured to irradiate layers of uncured filled resin material and deposited layers of the composition is provided. A method of three dimensionally printing a dental article is also provided.
    Type: Application
    Filed: November 15, 2016
    Publication date: March 16, 2017
    Inventors: Naim KARAZIVAN, Hiu LU, Thomas ERTL
  • Compositions comprising and methods of using norfluoxetine
    Publication number: 20070078188
    Abstract: The invention encompasses methods of using racemic and enantiomerically pure norfluoxetine, as well as pharmaceutical compositions, pharmaceutical unit dosage forms, and kits comprising racemic and enantiomerically pure norfluoxetine. In particular, the invention encompasses a method of inhibiting or reducing the production of PGE2. The invention further encompasses a method of treating or preventing inflammation in a patient, as well as a method of treating or preventing a disease or disorder such as, but not limited to, autoimmune diseases, arthritis, neurologic diseases, inflammatory diseases, fibromyalgia, pain resulting from inflammation, neuropathic pain, and cancer.
    Type: Application
    Filed: April 20, 2006
    Publication date: April 5, 2007
    Inventors: Mark Currie, Steven Jones, Chrisantha Senanayake, Zhi-Hiu Lu
  • Methods of using norfluoxetine
    Patent number: 7034059
    Abstract: The invention encompasses methods of using racemic and enantiomerically pure norfluoxetine, as well as pharmaceutical compositions, pharmaceutical unit dosage forms, and kits comprising racemic and enantiomerically pure norfluoxetine. In particular, the invention encompasses a method of inhibiting or reducing the production of PGE2. The invention further encompasses a method of treating or preventing inflammation in a patient, as well as a method of treating or preventing a disease or disorder such as, but not limited to, autoimmune diseases, arthritis, neurologic diseases, inflammatory diseases, fibromyalgia, pain resulting from inflammation, neuropathic pain, and cancer.
    Type: Grant
    Filed: June 28, 2002
    Date of Patent: April 25, 2006
    Assignee: Sepracor Inc.
    Inventors: Mark G. Currie, Steven W. Jones, Chrisantha H. Senanayake, Zhi-Hiu Lu
  • Methods of using norfluoxetine
    Publication number: 20030096019
    Abstract: The invention encompasses methods of using racemic and enantiomerically pure norfluoxetine, as well as pharmaceutical compositions, pharmaceutical unit dosage forms, and kits comprising racemic and enantiomerically pure norfluoxetine. In particular, the invention encompasses a method of inhibiting or reducing the production of PGE2. The invention further encompasses a method of treating or preventing inflammation in a patient, as well as a method of treating or preventing a disease or disorder such as, but not limited to, autoimmune diseases, arthritis, neurologic diseases, inflammatory diseases, fibromyalgia, pain resulting from inflammation, neuropathic pain, and cancer.
    Type: Application
    Filed: June 28, 2002
    Publication date: May 22, 2003
    Inventors: Mark G. Currie, Steven W. Jones, Chrisantha H. Senanayake, Zhi-Hiu Lu